Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension

American Journal of Hypertension

Volumn 16, Issue 1, 2003, Pages 51-58

  Glasser, Stephen P ^a   Neutel, Joel M ^b   Gana, Theophilus J ^c   Albert, Kenneth S ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Biovail Technologies Ltd   (United States)

Author keywords

Chronotherapy; Diltiazem extended release; Hypertension; Nighttime dosing

Indexed keywords

DILTIAZEM;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CHRONOTHERAPY; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; ESSENTIAL HYPERTENSION; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SINUSITIS; STATISTICAL ANALYSIS; SUSTAINED RELEASE PREPARATION; SYSTOLIC BLOOD PRESSURE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DELAYED-ACTION PREPARATIONS; DILTIAZEM; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0037230462     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(02)03153-9     Document Type: Article

References (26)

1. Muller JE, Ludmer PL, Willich SN, Tofler GH, Aylmer G, Klangos I, Stone PH: Circadian variation in the frequency of sudden cardiac death. Circulation 1987;75:131-138.
2. Marler JR, Price TR, Clark GL, Muller JE, Robertson T, Mohr JP, Hier DB, Wolf PA, Caplan LR, Foulkes MA: Morning increase in onset of ischemic stroke. Stroke 1989;20:473-476.
3. Rocco MB, Barry J, Campbell S, Nabel E, Cook EF, Goldman L, Selwyn AP: Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987;75:395-400.
4. Hausmann D, Lichtlen PR, Nikutta P, Wenzlaff P, Daniel WG: Circadian variation of myocardial ischemia in patients with stable coronary artery disease. Chronobiol Int 1991;8:385-398.
5. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, Poole WK, Passamani E, Roberts R, Robertson T, Sobel BE, Willerson JT, Braunwald E: Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313:1315-1322.
6. Willich SN, Linderer T, Wegscheider K, Leizorovicz A, Alamercery L Schroder R, and the ISLAM Study Group: Increased morning incidence of myocardial infarction in the ISLAM study: Absence with prior beta-adrenergic blockade. Circulation 1989;80:853-858.
7. Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE: Circadian variation in the incidence of sudden cardiac death in the Framingham heart study population. Am J Cardiol 1987;60:801-806.
8. Tofler GH, Brezinski D, Schafer AI, Czeisler CA, Rutherford JD, Willich SN, Gleason RE, Williams GH, Muller JE: Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987;316:1514-1518.
9. Weber MA, Drayer JI, Nakamura DK, Wyle FA: The circadian blood pressure pattern in ambulatory normal subjects. Am J Cardiol 1984;54:115-119.
10. Drayer JI, Weber MA, Nakamura DK: Automated ambulatory blood pressure monitoring: a study in age-matched normotensive and hypertensive men. Am Heart J 1985;109:1334-1338.
11. Diltiazem (GRD): Data on file. Biovail Laboratories, Inc., Chantilly, Virginia.
12. Neutel JM, Johnson R: Current challenges in the management of hypertension: effective single-dose monotherapy with a novel formulation of diltiazem. Advances in Therapy 1996;13:245-259.
13. Smith DHG, Neutel JM, Weber MA: Comparisons of the effects of different long-acting delivery systems on the pharmacokinetics and pharmacodynamics of diltiazem. Am J Hypertens 1999;12:1030-1037.
14. Lacourciere Y, Poirier L, Lefebvre J, Burford RG: Clinical efficacy of force titrated doses of diltiazem extended-release. A placebo-controlled study. Am J Hypertens 1995;8:282-286.
15. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordinating Committee: The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997;157:2413-2446.
16. Neutel JM, Smith DHG, Frishman WH: Optimization of antihypertensve therapy with a novel, extended release formulation of diltiazem: results of a practice-based clinical study. Clin Ther 1997;19: 1379-1393.
17. Biovail Pharmaceuticals, Inc: Cardizem CD Product Monograph. Physician's Desk Reference. Montvale, NJ, Medical Economics Company, Inc., 2002, pp 1016-1018.
18. White WB, Lund-Johansen P, Omvik P: Twenty-four hour blood pressure load as a surrogate end point in assessing antihypertensive therapy. J Hypertens 1993; 11 (Suppl 4):S75-S80.
19. Mancia G, Omboni S, Ravogli A, Parati G, Zanchetti A: Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: Additional information from a large data base. Blood Pressure 1995;4:148-156.
20. Pool PE: Anomalies in the dosing of diltiazem. Clin Cardiol 2000; 23:18-23.
21. Materson BJ Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J, Ramirez EA, Henderson WG, for the Department of Veteran Affairs Cooperative Study Group on Antihypertensive Agents: Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328:914-921.
22. Materson BJ Reda DJ, Cushman WC: Department of Veteran Affairs Single-Drug Therapy of Hypertension Study. Revised figures and new data. Am Heart J 1995;8:189-192.
23. White WB: Heart rate and the rate-pressure product as determinants of cardiovascular risk in patients with hypertension. Am J Hypertens 1999;12(Suppl):50S-55S.
24. Kannel WB: Update on hypertension as a cardiovascular risk factor, in Mancia G, Chalmers J, Julius S, Saruta T, Weber MA, Ferrari AU, Wilkinson IB (eds): Manual of Hypertension. New York, Churchill Livingstone, 2002, p. 3-19.
25. Deedwania PC, Nelson JR: Pathophysiology of silent myocardial ischemia during daily life: hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring. Circulation 1990;82:1296-1304.
26. Gillman MW, Kannel WB, Belanger A, D'Agostino RB: Influence of heart rate on mortality among persons with hypertension: The Framingham Study. Am Heart J 1993;125:1148-1154.